Understanding the burden of cognitive impairment associated with schizophrenia: results from the international LUCIA study

Background: Cognitive impairment associated with schizophrenia (CIAS) is a prevalent and clinically meaningful feature of Schizophrenia, yet real-world data on its recognition and impact across care settings are limited.The 'deLphi to Understand the burden of Cognitive Impairment Associated with schizophrenia' (LUCIA) is an international multistakeholder study that explored awareness, assessment practices, and the burden of CIAS to inform future care pathways. Methods: A three-phase, Delphi-informed design was applied, comprising of expert interviews (n = 11) to frame enquiry, qualitative interviews with health-and social-care professionals (HCPs; n = 74) and caregiver advocates (n = 11), two waves of a Delphi survey (n=449 and n= 343 HCPs in wave 1 and 2, respectively ) and a one wave survey for patients (n=61) and caregivers (n=112) across 15 countries (n=964).Results: The results showed poor awareness of CIAS across stakeholders.Structured cognitive assessment was infrequent and clinicians largely relied on the dementia-oriented Mini-Mental State Examination (MMSE) rather than schizophrenia-specific tools, citing time, training, and unclear actionability as key barriers.

Authors

Institutions

Publication Details

Journal
European Psychiatry
Published
2026-04-28
DOI
https://doi.org/10.1192/j.eurpsy.2026.12208
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Understanding the burden of cognitive impairment associated with schizophrenia: results from the international LUCIA study

Silvana Galderisi, Åsa Konradsson‐Geuken, Satoru Ikezawa, Walter D. Lawhorn et al.
European Psychiatry
Schizophrenia research and treatment
article

Understanding the burden of cognitive impairment associated with schizophrenia: results from the international LUCIA study

Silvana Galderisi, Åsa Konradsson‐Geuken, Satoru Ikezawa, Walter D. Lawhorn, Monique van der Weijden-Germann, Sébastien Tulliez, Bregt Kappelhoff, Robert A. McCutcheon, Ana Fernández, Christoph U. Correll, Sheykhi Hagaieg Morgane, Kari Skau, Maite Artés
article en

Abstract

Background: Cognitive impairment associated with schizophrenia (CIAS) is a prevalent and clinically meaningful feature of Schizophrenia, yet real-world data on its recognition and impact across care settings are limited.The 'deLphi to Understand the burden of Cognitive Impairment Associated with schizophrenia' (LUCIA) is an international multistakeholder study that explored awareness, assessment practices, and the burden of CIAS to inform future care pathways. Methods: A three-phase, Delphi-informed design was applied, comprising of expert interviews (n = 11) to frame enquiry, qualitative interviews with health-and social-care professionals (HCPs; n = 74) and caregiver advocates (n = 11), two waves of a Delphi survey (n=449 and n= 343 HCPs in wave 1 and 2, respectively ) and a one wave survey for patients (n=61) and caregivers (n=112) across 15 countries (n=964).Results: The results showed poor awareness of CIAS across stakeholders.Structured cognitive assessment was infrequent and clinicians largely relied on the dementia-oriented Mini-Mental State Examination (MMSE) rather than schizophrenia-specific tools, citing time, training, and unclear actionability as key barriers.

European Psychiatry
Uppsala University (SE), The King's College (US), University of Campania "Luigi Vanvitelli" (IT), Deutsche Telekom (Austria) (AT), Oxford Health NHS Foundation Trust (GB), University of Oxford (GB), German Center for Pediatric and Adolescent Rheumatology (DE), Einstein Center Digital Future (DE), Inland Hospital (NO), Boehringer Ingelheim (Taiwan) (TW), National Center of Neurology and Psychiatry (JP), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US), Huisarts en Wetenschap (NL), Boehringer Ingelheim (Egypt) (EG), Boehringer Ingelheim (China) (CN), European Federation of Nurses Associations (BE), Boehringer Ingelheim (United States) (US), Schizophrenia Research Institute (AU), Charité - Universitätsmedizin Berlin (DE)
No poverty
Openalex Percentile: Top 11%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.